Determination of Minimum Training Sample Size for Microarray-Based Cancer Outcome Prediction-An Empirical Assessment

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Shao, Li ^a   Fan, Xiaohui ^a   Cheng, Ningtao ^b   Wu, Leihong ^a   Cheng, Yiyu ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLASSIFIER; CONTROLLED STUDY; EVENT FREE SURVIVAL; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; NEUROBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; QUALITY CONTROL; SAMPLE SIZE; SIGNAL NOISE RATIO; SUPPORT VECTOR MACHINE; TREATMENT RESPONSE;

GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; MODELS, STATISTICAL; NEOPLASMS; PROGNOSIS; SAMPLE SIZE; SIGNAL-TO-NOISE RATIO;

EID: 84879812069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068579     Document Type: Article

References (24)

1. Fan XH, Shi LM, Fang H, Cheng YY, Perkins R, et al. (2010) DNA Microarrays Are Predictive of Cancer Prognosis: A Re-evaluation. Clin Cancer Res 16: 629-636.
2. Brown PO, Botstein D, (1999) Exploring the new world of the genome with DNA microarrays. Nat Genet 21: 33-37.
3. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14: 457-460.
4. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, et al. (2004) Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22: 2284-2293.
5. van de Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
6. The MicroArray Quality Control Consortium (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Pharmacogenomics J: S5-S16.
7. Kundu S, Martinsek AT, (1998) Using a stopping rule to determine the size of the training sample in a classification problem. Stat Probab Lett 37: 19-27.
8. Hwang DH, Schmitt WA, Stephanopoulos G, (2002) Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics 18: 1184-1193.
9. Gadbury GL, Page GP, Edwards J, Kayo T, Prolla TA, et al. (2004) Power and sample size estimation in high dimensional biology. Stat Methods Med Res 13: 325-338.
10. Fu WJJ, Dougherty ER, Mallick B, Carroll RJ, (2005) How many samples are needed to build a classifier: a general sequential approach. Bioinformatics 21: 63-70.
11. Dobbin KK, Simon RM, (2007) Sample size planning for developing classifiers using high-dimensional DNA microarray data. Biostatistics 8: 101-117.
12. de Valpine P, Bitter HM, Brown MPS, Heller J, (2009) A simulation-approximation approach to sample size planning for high-dimensional classification studies. Biostatistics 10: 424-435.
13. Figueroa RL, Zeng-Treitler Q, Kandula S, Ngo LH (2012) Predicting sample size required for classification performance. BMC Med Inform Decis Mak 12.
14. Kim KY, Chung HC, Rha SY, (2009) A weighted sample size for microarray datasets that considers the variability of variance and multiplicity. J Biosci Bioeng 108: 252-258.
15. Dobbin KK, Zhao Y, Simon RM, (2008) How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 14: 108-114.
16. Van Niel TG, McVicar TR, Datt B, (2005) On the relationship between training sample size and data dimensionality: Monte Carlo analysis of broadband multi-temporal classification. Remote Sens Environ 98: 468-480.
17. Popovici V, Chen WJ, Gallas BG, Hatzis C, Shi WW, et al. (2010) Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Res 12.
18. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947.
19. Wang YX, Klijn JGM, Zhang Y, Sieuwerts A, Look MP, et al. (2005) Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
20. Symmans WF, Hatzis C, Sotiriou C, Andre F, Peintinger F, et al. (2010) Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer. J Clin Oncol 28: 4111-4119.
21. Matthews BW, (1975) Comparison of predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 405: 442-451.
22. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
23. Mukherjee S, Tamayo P, Rogers S, Rifkin R, Engle A, et al. (2003) Estimating dataset size requirements for classifying DNA microarray data. Journal of Computational Biology 10: 119-142.
24. Dudoit S, Fridlyand J, Speed TP, (2002) Comparison of discrimination methods for the classification of tumors using gene expression data. Journal of the American Statistical Association 97: 77-87.